Advertisement Immucor Establishes Product Surveillance and Improvement Department - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Immucor Establishes Product Surveillance and Improvement Department

Immucor, Inc. (Immucor), a provider of automated instrument-reagent systems to the blood transfusion industry, has established product surveillance and improvement department to support the quality system initiative underway. With a focus on product quality, this new department will provide a single internal focal point to monitor quality issues, whether identified through internal or external sources, and initiate the appropriate corrective actions.

We will continue to evaluate our operations and organization to ensure they are in line with our commitment to develop high quality systems, stated Dr. Gioacchino De Chirico, Immucor’s president and chief executive officer. Our new Product Surveillance and Improvement Department is an important example of our drive to modernize our quality approach.